Cell Cycle/Checkpoint
Cell Cycle/Checkpoint(细胞周期/检查点)
Cell Cycle
Cells undergo a complex cycle of growth and division that is referred to as the cell cycle. The cell cycle consists of four phases, G1 (GAP 1), S (synthesis), G2 (GAP 2) and M (mitosis). DNA replication occurs during S phase. When cells stop dividing temporarily or indefinitely, they enter a quiescent state called G0. read more
- ATM/ATR(29)
- Aurora Kinase(58)
- Cdc42(4)
- Cdc7(3)
- Chk(14)
- c-Myc(27)
- CRM1(8)
- Cyclin-Dependent Kinases(77)
- E1 enzyme(1)
- G-quadruplex(12)
- Haspin(6)
- HMTase(1)
- Kinesin(27)
- Ksp(4)
- Microtubule/Tubulin(257)
- Mps1(15)
- Mitotic(7)
- RAD51(13)
- ROCK(74)
- Rho(13)
- PERK(11)
- PLK(43)
- PTEN(6)
- Wee1(9)
- PAK(25)
- Arp2/3 Complex(8)
- Dynamin(14)
- ECM & Adhesion Molecules(54)
- Cytoskeleton & Motor Proteins(65)
- Endomembrane System & Vesicular Trafficking(36)
- G1(51)
- Genotoxic Stress(23)
- G2/M(40)
- G2/S(17)
- Inositol Phosphates(67)
- Proteolysis(183)
- Cellular Chaperones(14)
- Cyclin G-associated Kinase (GAK)(1)
- MARK(3)
- NEKs(1)
Cell Cycle/Checkpoint 相关产品(1379)
- GC10069NSC 23766 trihydrochlorideCAS: 1177865-17-6纯度: >99.50% / >99.00%
NSC 23766 trihydrochloride是一种选择性Rac1 GTPase抑制剂,通过特异性阻断Rac1的鸟嘌呤核苷酸交换因子Trio和Tiam1来抑制Rac1的激活,对Rac1的IC₅₀约为50μM。
- GC10115360A iodideCAS: 737763-37-0纯度: >98.00%
360A iodide是一种G-四联体(G-quadruplex)的稳定剂,360A iodide还是有效的端粒酶(telomerase;IC 50 =300nM)的活性抑制剂
- GC11224BI6727(Volasertib)CAS: 755038-65-4纯度: >99.00%
BI6727(Volasertib)是一种口服ATP竞争性Polo样激酶(PLK)抑制剂,可强效抑制PLK1、PLK2和PLK3活性,IC 50 值分别为0.87nM、5nM和56nM。
- GC11511Vincristine sulfateCAS: 2068-78-2纯度: >99.50%
An antimitotic inhibitor of tubulin polymerization
- GC11549VX-680 (MK-0457,Tozasertib)CAS: 639089-54-6纯度: >99.50%
VX-680 (MK-0457,Tozasertib)是一种有效的Aurora激酶抑制剂,对Aurora A/B/C的K i 值分别为0.6、18、4.6nM,具有抗癌活性。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10008 | GSK1070916 | 942918-07-2 | >98.50% | |
A potent inhibitor of Aurora B and C kinases | ||||
| GC10030 | EHop-016 | 1380432-32-5 | >99.00% | |
EHop-016是一种高效的Rac GTP酶Rac1抑制剂,IC 50 值为1.1μM。 | ||||
| GC10069 | NSC 23766 trihydrochloride | 1177865-17-6 | >99.50% / >99.00% | |
NSC 23766 trihydrochloride是一种选择性Rac1 GTPase抑制剂,通过特异性阻断Rac1的鸟嘌呤核苷酸交换因子Trio和Tiam1来抑制Rac1的激活,对Rac1的IC₅₀约为50μM。 | ||||
| GC10115 | 360A iodide | 737763-37-0 | >98.00% | |
360A iodide是一种G-四联体(G-quadruplex)的稳定剂,360A iodide还是有效的端粒酶(telomerase;IC 50 =300nM)的活性抑制剂 | ||||
| GC10163 | MLN0905 | 1228960-69-7 | >97.00% | |
A Plk1 inhibitor | ||||
| GC10196 | ETP-46464 | 1345675-02-6 | >98.00% | |
An ATR inhibitor | ||||
| GC10251 | FRAX1036 | 1432908-05-8 | >99.00% | |
A selective PAK1 inhibitor | ||||
| GC10334 | INH6 | 1001753-24-7 | >99.00% | |
A Hec1/Nek2 inhibitor | ||||
| GC10479 | PHA-680632 | 398493-79-3 | >99.50% | |
An Aurora kinase inhibitor | ||||
| GC10521 | Podophyllotoxin | 518-28-5 | >99.50% | |
A lignan with diverse biological activities | ||||
| GC10638 | AT9283 | 896466-04-9 | >99.50% | |
A broad spectrum kinase inhibitor | ||||
| GC10840 | THZ1 | 1604810-83-4 | >98.50% | |
A covalent Cdk7 inhibitor | ||||
| GC10842 | LEE011 | 1211441-98-3 | >99.50% | |
LEE011是一种具有口服活性的特异性细胞周期蛋白依赖性激酶CDK4/6抑制剂。LEE011以纳摩尔浓度靶向cyclin D1/CDK4和cyclin D3/CDK6。 | ||||
| GC11007 | VO-Ohpic trihydrate | 476310-60-8 | >98.00% | |
A specific inhibitor of PTEN | ||||
| GC11085 | TAK-901 | 934541-31-8 | >98.00% | |
A non-selective inhibitor of Aurora kinases | ||||
| GC11118 | KU 55933 | 587871-26-9 | >99.50% | |
KU 55933是一种高效且特异的ATM激酶抑制剂,能够使人类肿瘤细胞对电离辐射和化疗药物更加敏感。KU 55933在体外的IC₅₀值为13nM,K i 值为2.2nM。 | ||||
| GC11202 | Epothilone A | 152044-53-6 | >98.50% | |
An antimicrotubule agent | ||||
| GC11224 | BI6727(Volasertib) | 755038-65-4 | >99.00% | |
BI6727(Volasertib)是一种口服ATP竞争性Polo样激酶(PLK)抑制剂,可强效抑制PLK1、PLK2和PLK3活性,IC 50 值分别为0.87nM、5nM和56nM。 | ||||
| GC11310 | CCT129202 | 942947-93-5 | >98.00% | |
An Aurora kinase inhibitor | ||||
| GC11324 | PHA-767491 | 845714-00-3 | - | |
A potent Cdc7 kinase inhibitor | ||||
| GC11511 | Vincristine sulfate | 2068-78-2 | >99.50% | |
An antimitotic inhibitor of tubulin polymerization | ||||
| GC11549 | VX-680 (MK-0457,Tozasertib) | 639089-54-6 | >99.50% | |
VX-680 (MK-0457,Tozasertib)是一种有效的Aurora激酶抑制剂,对Aurora A/B/C的K i 值分别为0.6、18、4.6nM,具有抗癌活性。 | ||||
| GC11621 | GW843682X | 660868-91-7 | >99.50% | |
A reversible polo-like kinase inhibitor | ||||
| GC11648 | BML-277 | 516480-79-8 | >98.00% | |
A selective DNA damage control kinase inhibitor | ||||
